CERo Therapeutics, Inc. Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236
06 juin 2024 08h00 HE
|
CERo Therapeutics Holdings, Inc.
Company continuing IND-enabling activities in preparation for submission of Investigational New Drug Application to FDA SOUTH SAN FRANCISCO, Calif., June 06, 2024 (GLOBE NEWSWIRE) -- CERo...
Telomir Pharmaceuticals, Inc. Signs Media Deal with New to The Street for Network Interview Broadcasts, Billboards, and TV Commercial Support
16 mai 2024 09h30 HE
|
FMW Media Works Corp
Telomir Pharmaceuticals, Inc. (NASDAQ: TELO)Signs Media Deal with New to The Street for Network Interview Broadcasts, Billboards, and TV Commercial Support
Medicenna Announces First Patient Dosed in ABILITY-1 Study of MDNA11 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Solid Tumors
13 févr. 2024 07h00 HE
|
Medicenna Therapeutics Corp.
The ABILITY-1 Study is evaluating MDNA11, a highly selective long-acting IL-2 Superkine, in combination with KEYTRUDA® (pembrolizumab) for treatment of patients with advanced solid tumorsMDNA11...
New to The Street TV Features Five Corporate Guest Interviews, Episode 537 Airs on the FOX Business Network, Monday, December 11, 2023, at 10:30 PM PT
08 déc. 2023 09h46 HE
|
FMW Media Works Corp
New to The Street TV Features Five Corporate Guest Interviews, Episode 537 Airs on the FOX Business Network, Monday, December 11, 2023, at 10;30 PM PT
New to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored Program on Bloomberg TV, Tonight, Thursday, December 7, 2023, at 9:30 PM PT
07 déc. 2023 09h20 HE
|
FMW Media Works Corp
New to The Street TV Announces Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored Program on Bloomberg TV, Dec. 7. 9:30 PM PT
Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting
08 nov. 2023 07h30 HE
|
HCW Biologics, Inc
Preliminary data readout from a Phase 1 study to evaluate HCW9218, the lead drug candidate of HCW Biologics, in solid tumors.
New to The Street Announces Six Business Interviews on its 524th Show, Airing on the Fox Business Network, Monday, October 23, 2023, at 10:30 PM PT
20 oct. 2023 10h43 HE
|
FMW Media Works Corp
FMW Media's New to The Street, a national TV show, announces episode 524th airing on the Fox Business Network, Monday, October 23, 2023, at 10:30 PM PT
New to The Street Airs Televised Corporate Interviews Episodes 521 and 522 as Sponsored Programming on Bloomberg TV and The Fox Business Network
13 oct. 2023 09h12 HE
|
FMW Media Works Corp
New to The Street Airs Televised Corporate Interviews Episodes 521 and 522 as Sponsored Programming on Bloomberg TV and The Fox Business Network.
New to The Street Announces TV Corporate Appearances, Broadcasting Episode 518 on Newsmax and Episode 519 on FOX Business Network, Airings start on Saturday, October 7, 2023, at 3:30 PM ET
06 oct. 2023 09h30 HE
|
FMW Media Works Corp
New to The Street airs Episode 518 on Newsmax and Episode 519 on the FOX Business Network.
Medical Components Inc. and Truveta partner to advance care for patients living with cancer and chronic kidney disease
12 sept. 2023 09h00 HE
|
Truveta
BELLEVUE, Wash., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Medical Components, Inc. is partnering with Truveta to advance the use of real-world data to improve clinical care for patients battling cancer...